Latest

Latest AstraZeneca News | Page 3

  • Latest AstraZeneca news stories and updates. What is happening today? All recent AstraZeneca news and developments. Live coverage and timeline of AstraZeneca. All you need to know about AstraZeneca.
AstraZeneca plans to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines
AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock Exchange
AstraZeneca appoints Joris Silon as Head of Investor Relations
Saphnelo self-administration TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in systemic lupus erythematosus disease activity
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
Cornell showcases a decade of impact through new community-engaged learning video series
Blood test offers hope for more effective ovarian cancer treatment
Finalists Announced For 2025 National Stroke Awards
ABC exposes Federal Government’s broken COVID-19 Vaccine Injury Claims Scheme
New research calls for lived experiences to improve cancer care and support
Global recognition for a pioneering marketing research leader
RFK Junior is stoking fears about vaccine safety. Here’s why he’s wrong – and the impact it could have
How pregnant women are tested for gestational diabetes is changing. Here’s what this means for you
Urban environments significantly increase risk of developing asthma – new research
Cancer patients from migrant backgrounds have a 1 in 3 chance of something going wrong in their care
First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune disease, NMOSD
How Beijing plans to bounce back against Trump’s tariffs
Protein In Nose Provides Information About COPD
5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
ITSN1 Gene Linked To Risk Of Parkinson’s Disease
AI accelerates discovery of neurodevelopmental disorder-associated genes
Ehrenberg-Bass has earned the undivided respect of global brands over 20 years
Elon Musk Talks ‘Tech Support’ Governance as World Leaders Champion Innovation-Driven Reforms at Dubai Summit
Cracking the code of lethal antibodies in a new blood-clotting disorder
Patients continue to be prioritised
New Year, New Medicines
New Research Reveals Two Types Of Fatty Liver Disease
First new treatment for asthma and COPD in half a century – new study
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
Enzyme engineering has the potential to drive green, more efficient drug manufacturing
One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics
What pathogen might spark the next pandemic? How scientists are preparing for ‘disease X’
An oral weight loss pill has just passed early trials with promising results – here’s how it works
Amcor Announces Changes To Board Of Directors
Businesses that try to come clean about their impact on nature can end up concealing more than they reveal
New study reveals sex-specific gene expression in adipose stem cells of mice
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots
Bone-building drug which prevents fractures in people with osteoporosis approved for use in UK – here’s how it works
Genetics of COPD important for lung function in young people
Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes
Weight-loss jabs linked to lower cancer risk compared with insulin – new study
Targeting leukemia’s survival route: a novel approach to overcoming leukemia recurrence
Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
Masks work, our comprehensive review has found
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

© 2026 - The National Tribune Australia